BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2360261)

  • 1. The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation.
    Bianco JA; Higano C; Singer J; Appelbaum FR; McDonald GB
    Transplantation; 1990 Jun; 49(6):1194-5. PubMed ID: 2360261
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child.
    Beckman RA; Siden R; Yanik GA; Levine JE
    J Pediatr Hematol Oncol; 2000; 22(4):344-50. PubMed ID: 10959906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
    Morton AJ; Durrant ST
    Clin Transplant; 1995 Jun; 9(3 Pt 1):205-8. PubMed ID: 7549062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.
    Ely P; Dunitz J; Rogosheske J; Weisdorf D
    Am J Med; 1991 Jun; 90(6):707-10. PubMed ID: 2042686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
    Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
    J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in the management of diarrhea induced by graft versus host disease.
    Ippoliti C; Neumann J
    Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
    Pai V; Porter K; Ranalli M
    Pediatr Blood Cancer; 2011 Jan; 56(1):45-9. PubMed ID: 21108438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide in the management of treatment-related diarrhoea.
    Baillie-Johnson HR
    Anticancer Drugs; 1996 Jan; 7 Suppl 1():11-5. PubMed ID: 8822080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea.
    Walker JJ; Kaplan DS
    Am J Gastroenterol; 1993 May; 88(5):765-7. PubMed ID: 8480746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
    Yavuz MN; Yavuz AA; Aydin F; Can G; Kavgaci H
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):195-202. PubMed ID: 12182992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies.
    Kornblau S; Benson AB; Catalano R; Champlin RE; Engelking C; Field M; Ippoliti C; Lazarus HM; Mitchell E; Rubin J; Stiff PJ; Vokes E; Wadler S
    J Pain Symptom Manage; 2000 Feb; 19(2):118-29. PubMed ID: 10699539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease: unexpected presentation with simultaneous hepatitis and pancreatitis.
    Fernandes SR; Alves AT; Cortes MB; Cortez-Pinto H
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27485875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigmoid volvulus presenting as chronic secretory diarrhea responsive to octreotide.
    Almog Y; Dranitzki-Elhalel M; Lax E; Zimmerman J; Glaser B
    Am J Gastroenterol; 1992 Jan; 87(1):148-50. PubMed ID: 1728114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide acetate in refractory bone marrow transplant-associated diarrhea.
    Crouch MA; Restino MS; Cruz JM; Perry JJ; Hurd DD
    Ann Pharmacother; 1996 Apr; 30(4):331-6. PubMed ID: 8729883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and outcome of diarrhea after marrow transplantation: a prospective study.
    Cox GJ; Matsui SM; Lo RS; Hinds M; Bowden RA; Hackman RC; Meyer WG; Mori M; Tarr PI; Oshiro LS
    Gastroenterology; 1994 Nov; 107(5):1398-407. PubMed ID: 7926504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked improvement of diabetic diarrhea with the somatostatin analogue octreotide.
    Nakabayashi H; Fujii S; Miwa U; Seta T; Takeda R
    Arch Intern Med; 1994 Aug; 154(16):1863-7. PubMed ID: 8053756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe diabetic diarrhea successfully treated with octreotide, a somatostatin analogue.
    Murao S; Hirata K; Ishida T; Takahara J
    Endocr J; 1999 Jun; 46(3):477-8. PubMed ID: 10504003
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic diarrhoea after allogenic bone marrow transplantation.
    Radu B; Allez M; Gornet JM; Lemann M; Socie G; Gluckman E; Zagdanski AM
    Gut; 2005 Jan; 54(1):161, 174. PubMed ID: 15591522
    [No Abstract]   [Full Text] [Related]  

  • 19. [The usefulness of the somatostatin analog SMS 201-995 in treating Cryptosporidium-induced diarrhea associated with the acquired immunodeficiency syndrome].
    Santos Gil I; Mur Gimeno P; Herreros Fernández M; del Arco Galán C
    Med Clin (Barc); 1990 Dec; 95(20):796. PubMed ID: 2131392
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults.
    Kanojia MD; Anagnostou AA; Zander AR; Vellekoop L; Spitzer G; Verma DS; Jagannath S; Dicke KA
    Transplantation; 1984 Mar; 37(3):246-9. PubMed ID: 6367162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.